NO950255L - Use of alpha, omega-dicarboxylic acids as fibrinogen reducing agents - Google Patents
Use of alpha, omega-dicarboxylic acids as fibrinogen reducing agentsInfo
- Publication number
- NO950255L NO950255L NO950255A NO950255A NO950255L NO 950255 L NO950255 L NO 950255L NO 950255 A NO950255 A NO 950255A NO 950255 A NO950255 A NO 950255A NO 950255 L NO950255 L NO 950255L
- Authority
- NO
- Norway
- Prior art keywords
- omega
- alpha
- dicarboxylic acids
- reducing agents
- fibrinogen
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Anvendelse av a, u-dikarboksyl- syre med formel I X R, R, X HOOC- C- C- Q- C- C- COOH l l l (D R2 Y hvori X og Y, som kan være like eller forskjellige, betegner hydrogen, halogen, Cj-C6- alkyl, Cj-C6-alkoksy, hydroksy, cyano, karboksyl, Cj-Cj-alkoksykarbonyl eller karbamoyl, R! og R2, som kan være like eller forskjellige, betegner hydrogen eller Cj-Cj-alkyl, og Q betegner en lineær, mettet eller umettet alkylenkjede med 2-14 C- atomer, hvori ett eller flere C- atomer kan erstattes med syklo- alkylringer, fenyl eller hetero- sykliske grupper, så vel som deres In vlvo hydrolyserbare karboksylsyrederivater for fremstilling av legemidler med fibrinogenreduserene virkning.Use of a, u-dicarboxylic acid of formula IXR, R, X HOOC-C-C-Q-C-C-COOH III (D R2 Y wherein X and Y, which may be the same or different, represent , C 1 -C 6 alkyl, C 1 -C 6 alkoxy, hydroxy, cyano, carboxyl, C 1 -C 3 alkoxycarbonyl or carbamoyl, R 1 and R 2, which may be the same or different, represent hydrogen or C 1 -C 3 alkyl, and Q represents a linear, saturated or unsaturated alkylene chain having 2-14 C atoms, wherein one or more C atoms may be replaced by cycloalkyl rings, phenyl or heterocyclic groups, as well as their in vivo hydrolysable carboxylic acid derivatives for the preparation of drugs with fibrinogen-reducing effect.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4224670A DE4224670A1 (en) | 1992-07-25 | 1992-07-25 | Use of â, w-dicarboxylic acids as fibrinogens |
PCT/EP1993/001894 WO1994002128A1 (en) | 1992-07-25 | 1993-07-17 | USE OF α,w DICARBOXYLIC ACIDS AS FIBRINOGEN REDUCERS |
Publications (2)
Publication Number | Publication Date |
---|---|
NO950255L true NO950255L (en) | 1995-01-24 |
NO950255D0 NO950255D0 (en) | 1995-01-24 |
Family
ID=25916937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO950255A NO950255D0 (en) | 1992-07-25 | 1995-01-24 | Use of alpha, omega-dicarboxylic acids as fibrinogen reducing agents |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO950255D0 (en) |
-
1995
- 1995-01-24 NO NO950255A patent/NO950255D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO950255D0 (en) | 1995-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20034644D0 (en) | Fatty acids with half-chain, glycerides and analogues as neutrophil survival and activation factors | |
EE03139B1 (en) | Piperazine derivatives, their use and pharmaceutical composition | |
NO20021229D0 (en) | Benzamides and similar inhibitors of factor Xa | |
ATE282614T1 (en) | PHENYL UREA AND PHENYLTHIOUREA DERIVATIVES | |
AR025976A1 (en) | FAB INHIBITORS I. | |
DK0486666T3 (en) | Therapeutic heterocyclic compounds | |
CH692199A8 (en) | PYRIDIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS | |
ES2053133T3 (en) | NEW SULFONAMIDES DERIVED FROM BENZOCICLICOS OR BENZOHETEROCICLICOS ACIDS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS. | |
BR9106367A (en) | ANTI-INFLAMMATORY ACIDS AND N-HYDROXYURIAS | |
AR009376A1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING A TIAZOL DERIVATIVE FOR THE PREVENTION AND TREATMENT OF DISEASES CAUSED BY THE ABNORMAL PRODUCTION OF CYTOKINES AND / OR THE ACCELERATION OF THE ADHESION OF NEUTROPHILS AND / OR THE ABNORMAL PRODUCTION OF TNF-ALPHA AND THE USE OF DICH-ALPHA TIAZOL FOR LA PREPARAC | |
FI860369A0 (en) | IMMEDIATE SOLUTIONS, DERAS FRAMSTAELLNING OCH ANVAENDNING SAMT DESSA DERIVAT INNEHAOLLANDE PHARMACEUTICAL COMPOSITION. | |
FI844225L (en) | GRISEOLINSYRADERIVAT OCH DERAS ANVAENDNING. | |
DK0641770T3 (en) | New compounds with platelet aggregation inhibitory activity | |
AR029001A1 (en) | DERIVATIVES OF BENCIL-3,4-METHYLENDIOXYCHINAMIC AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
DE68906965D1 (en) | ANALGETIC PHENOTHIAZINE DERIVATIVES. | |
NO950255L (en) | Use of alpha, omega-dicarboxylic acids as fibrinogen reducing agents | |
ES2148561T3 (en) | PREVENTION AND CURE OF TYPE I ALLERGIC DISEASES. | |
ES2109530T3 (en) | DERIVATIVES OF FENYL-CYCLLOHEXANE-CARBOXYLIC ACIDS HETEROTRICICLICAMENTE SUBSTITUTED. | |
ATE74138T1 (en) | HEPTANOYL-GLU-ASP-ALA-AMINO ACID IMMUNOGANTS. | |
IT1216104B (en) | PEPTIDES WITH PHARMACEUTICAL ACTIVITY. | |
MX9304373A (en) | ALPHA ACIDS, OMEGA-DICARBOXILICOS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, FOR THE DECREASE OF FIBRINOGEN IN THE BLOOD. | |
IT1205114B (en) | 2-SELENOMETHYL-1,4-DIHYDROPYRIDINE, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DK460789A (en) | 2-AMINOACETAMIDE DERIVATIVES | |
WO1993022376A3 (en) | Amino compounds as processing stabilisers for thermoplastic materials | |
IT1216103B (en) | PEPTIDES WITH PHARMACEUTICAL ACTIVITY. |